Patents by Inventor Erling N. Petersen

Erling N. Petersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • .beta.-carboline-3-carboxylic acid derivatives, and their use as psychotropic and anti-epileptic agents
    Patent number: 4748180
    Abstract: New .beta.-carboline-3-carboxylic acid esters have the general formula I: ##STR1## wherein R.sup.4, R.sup.5 and R.sup.6 have specified meanings. The new compounds exhibit surprising psychotropic properties.
    Type: Grant
    Filed: October 9, 1986
    Date of Patent: May 31, 1988
    Assignee: Schering Aktiengesellschaft
    Inventors: Erling N. Petersen, Leif H. Jensen, Frank Watjen, Dieter Seidelmann
  • .beta.-carboline-3-oxadiazolyl derivatives, and their use as psychotropic agents
    Patent number: 4645773
    Abstract: New .beta.-carboline-3-oxadiazolyl derivatives have the general formula I: ##STR1## wherein X is ##STR2## and wherein R.sup.4, R.sup.A and R have specified meanings. These new compounds exhibit surprising psychotropic properties.
    Type: Grant
    Filed: May 15, 1985
    Date of Patent: February 24, 1987
    Assignee: Schering Aktiengesellschaft
    Inventors: Mogens Engelstoft, Tage Honore, Frank Watjen, Erling N. Petersen, Andreas Huth
  • .beta.-Carboline-3-carboxylic acid derivatives, and their use as psychotropic agents
    Patent number: 4631285
    Abstract: New .beta.-carboline-3-carboxylic acid esters have the general formula I: ##STR1## wherein R.sup.4, R.sup.5 and R.sup.6 have specified meanings. The new compounds exhibit surprising psychotropic properties.
    Type: Grant
    Filed: May 15, 1985
    Date of Patent: December 23, 1986
    Assignee: Schering Aktiengesellschaft
    Inventors: Erling N. Petersen, Leif H. Jensen, Frank Watjen, Dieter Seidelmann
  • (-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)meth yl]-1-methylpiperidine useful as 5-HT potentiator
    Patent number: 4593036
    Abstract: The compound (-)-trans-4-(4-florophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidin e and pharmaceutically-acceptable acid addition salts thereof, pharmaceutical compositions thereof, and their use in potentiating the 5-hydroxytryptamine(5-HT) of a subject in need thereof, for the alleviation of any of various physiological abnormalities, are disclosed.
    Type: Grant
    Filed: February 7, 1984
    Date of Patent: June 3, 1986
    Assignee: A/S Ferrosan
    Inventors: Jorgen B. Lassen, Jorgen A. Christensen, Erling N. Petersen, John B. Hansen
  • (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
    Patent number: 4585777
    Abstract: The compound (-)-trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine and pharmaceutically-acceptable acid addition salts thereof, pharmaceutical compositions thereof, and their use in potentiating the 5-hydroxytryptamine(5-HT) of a subject in need thereof, for the alleviation of any of various physiological abnormalities, are disclosed.
    Type: Grant
    Filed: February 7, 1984
    Date of Patent: April 29, 1986
    Assignee: A/S Ferrosan
    Inventors: Jorgen B. Lassen, Jorgen A. Christensen, Erling N. Petersen, John B. Hansen